The National Pharmaceutical Pricing Authority (NPPA) on December 19, 2024, issued the notification regarding the addendum to notification no 2291(E) dated June 14, 2024, regarding the ceiling price fixation of the scheduled formulation.
The following has been inserted namely: -
• Sl. No. 9 shall be added in Table ‘B’ as below: -
“M/s Jedux Parenteral Private Limited - JEDUX DOUBLE PORT WITH EURO HEAD, JPORT PLUS”
[Notification No. 5503(E)]